• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期肝病患者的重症监护治疗

Intensive Care Therapy for Patients with Advanced Liver Diseases.

作者信息

Katsounas Antonios, Canbay Ali

机构信息

Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Magdeburg, Germany.

出版信息

Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.

DOI:10.1159/000492088
PMID:30345286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6189546/
Abstract

Decompensated cirrhosis is characterized by high hospitalization rates and costs, frequent readmissions, and poor short-term survival. Patients admitted to the hospital with acute variceal bleeding and/or hepatic encephalopathy and/or renal dysfunction are at serious risk for developing infection and/or sepsis; in turn, this renders them highly susceptible to the development of multi-system organ failure. The lack of standardized intensive care unit management protocols in patients with cirrhosis along with only few data reports from longitudinal clinical trials makes it difficult for hepatologists and critical care specialists to provide uniform evidence for clinical practice that could safely consolidate favorable outcomes such as lower hospitalization rates and/or mortality. Based on a rigorous online search of the scientific literature as well as a longtime clinical experience of the authors in the field of hepatology and critical care medicine, this work represents a focused effort to elucidate the specific bio-morbidity of advanced liver diseases in relation to the aforementioned challenges in clinical management. Further meta-analyses and/or systematic reviews are needed to enable clinicians to develop more effective strategies to bridge patients with decompensated liver disease to recompensation or liver transplantation.

摘要

失代偿期肝硬化的特点是住院率高、费用高、频繁再入院以及短期生存率低。因急性静脉曲张出血和/或肝性脑病和/或肾功能不全入院的患者发生感染和/或脓毒症的风险很高;反过来,这使他们极易发生多系统器官衰竭。肝硬化患者缺乏标准化的重症监护病房管理方案,同时纵向临床试验的数据报告很少,这使得肝病学家和重症监护专家难以提供统一的临床实践证据,以安全巩固诸如降低住院率和/或死亡率等良好结果。基于对科学文献的严格在线搜索以及作者在肝病学和重症医学领域的长期临床经验,这项工作旨在集中阐明晚期肝病的特定生物发病率与上述临床管理挑战之间的关系。需要进一步的荟萃分析和/或系统评价,以使临床医生能够制定更有效的策略,将失代偿性肝病患者过渡到代偿或肝移植。

相似文献

1
Intensive Care Therapy for Patients with Advanced Liver Diseases.晚期肝病患者的重症监护治疗
Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.
2
Outcome of patients with cirrhosis admitted to intensive care.入住重症监护病房的肝硬化患者的治疗结果。
Curr Opin Crit Care. 2008 Apr;14(2):202-7. doi: 10.1097/MCC.0b013e3282f6a40d.
3
Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.急性慢性肝衰竭:重症监护病房的客观入院及支持标准
JHEP Rep. 2019 Mar 18;1(1):44-52. doi: 10.1016/j.jhepr.2019.02.005. eCollection 2019 May.
4
Predictive factors for 28-day mortality in acute-on-chronic liver failure patients admitted to the intensive care unit.预测 ICU 收治的慢加急性肝衰竭患者 28 天病死率的因素。
Dig Liver Dis. 2019 Oct;51(10):1416-1422. doi: 10.1016/j.dld.2019.04.008. Epub 2019 May 4.
5
Survival and predictors of outcome among patients with decompensated liver disease in a non-liver transplant intensive care unit. Pessimism is historical and unjustified.失代偿期肝病患者在非肝移植重症监护病房的生存和预后预测因素。悲观是历史的、没有依据的。
Intern Med J. 2019 Jun;49(6):745-752. doi: 10.1111/imj.14151.
6
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3.肝移植治疗失代偿期肝硬化患者:急性慢加急性肝衰竭 3 级的多中心研究
J Hepatol. 2017 Oct;67(4):708-715. doi: 10.1016/j.jhep.2017.06.009. Epub 2017 Jun 21.
7
The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.重症监护病房的急性慢性肝衰竭患者的治疗过程和结果与其他人群相当。
J Hepatol. 2018 Oct;69(4):803-809. doi: 10.1016/j.jhep.2018.04.025. Epub 2018 May 4.
8
Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.III 度肥胖是失代偿期肝硬化患者发生慢加急性肝衰竭的一个危险因素。
J Hepatol. 2018 Sep;69(3):617-625. doi: 10.1016/j.jhep.2018.04.016. Epub 2018 Apr 28.
9
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
10
Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.入院时肠道微生物群与肝硬化患者结局的关系。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):756-765.e3. doi: 10.1016/j.cgh.2018.07.022. Epub 2018 Jul 20.

引用本文的文献

1
[When should a liver disease patient be admitted to the intensive care unit?].[肝病患者何时应入住重症监护病房?]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):470-477. doi: 10.1007/s00063-024-01160-w. Epub 2024 Jul 17.
2
Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study.失代偿期肝硬化的重症监护结局:美国全国住院患者样本横断面研究。
Crit Care. 2024 May 7;28(1):150. doi: 10.1186/s13054-024-04938-8.
3
Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?慢性肝病合并抑郁症患者的抗抑郁药:何时适用以及如何选择合适的药物?
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101390. doi: 10.1016/j.jceh.2024.101390. Epub 2024 Feb 27.
4
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].[急诊与重症医学中急性失代偿期肝硬化的管理]
Anaesthesist. 2022 May;71(5):403-412. doi: 10.1007/s00101-022-01113-y. Epub 2022 Mar 31.
5
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].[急诊与重症医学中急性失代偿期肝硬化的管理]
Med Klin Intensivmed Notfmed. 2022 Feb;117(1):73-82. doi: 10.1007/s00063-021-00876-3. Epub 2021 Oct 12.
6
Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.急性慢性肝衰竭:重症监护病房的客观入院及支持标准
JHEP Rep. 2019 Mar 18;1(1):44-52. doi: 10.1016/j.jhepr.2019.02.005. eCollection 2019 May.
7
Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.肝硬化中的免疫功能障碍和白蛋白相关免疫。
Mediators Inflamm. 2019 Feb 25;2019:7537649. doi: 10.1155/2019/7537649. eCollection 2019.
8
Acute-on-Chronic Liver Failure.慢加急性肝衰竭
Visc Med. 2018 Aug;34(4):243-244. doi: 10.1159/000492588. Epub 2018 Aug 17.

本文引用的文献

1
Immunodysfunction in Acute-on-Chronic Liver Failure.慢加急性肝衰竭中的免疫功能障碍
Visc Med. 2018 Aug;34(4):276-282. doi: 10.1159/000488690. Epub 2018 Jul 3.
2
Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure.与慢加急性肝衰竭相关的感染性并发症的管理
Visc Med. 2018 Aug;34(4):261-268. doi: 10.1159/000491107. Epub 2018 Jul 27.
3
Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure.肝衰竭患者出血和侵入性操作期间凝血功能障碍的管理
Visc Med. 2018 Aug;34(4):254-258. doi: 10.1159/000491106. Epub 2018 Jul 16.
4
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.肝硬化合并细菌感染患者中 Sepsis-3 标准和快速 SOFA 的评估。
Gut. 2018 Oct;67(10):1892-1899. doi: 10.1136/gutjnl-2017-314324. Epub 2017 Aug 31.
5
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.氟马西尼与安慰剂或不进行干预对肝硬化和肝性脑病患者的影响。
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD002798. doi: 10.1002/14651858.CD002798.pub3.
6
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.来自合理粪便供体的粪便微生物群移植可改善肝性脑病:一项随机临床试验。
Hepatology. 2017 Dec;66(6):1727-1738. doi: 10.1002/hep.29306. Epub 2017 Oct 30.
7
Branched-chain amino acids for people with hepatic encephalopathy.用于肝性脑病患者的支链氨基酸
Cochrane Database Syst Rev. 2017 May 18;5(5):CD001939. doi: 10.1002/14651858.CD001939.pub4.
8
Probiotics for people with hepatic encephalopathy.用于肝性脑病患者的益生菌。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD008716. doi: 10.1002/14651858.CD008716.pub3.
9
Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology.肝病患者的重症监护管理:巴西肝病学会主办的单一主题会议论文集
Arq Gastroenterol. 2015 Dec;52 Suppl 1:55-72. doi: 10.1590/S0004-28032015000500004.
10
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.